Ultrasound-Guided Percutaneous Neuromodulation on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome: A Pilot Study
Trial Parameters
Brief Summary
Greater Trochanteric Pain Syndrome (GTPS) predominantly affects women, with an annual incidence of 1.8 to 5.6 per 1000 individuals and a prevalence ratio of 4:1 compared to men. It is characterized by lateral pain in the greater trochanter region, particularly during palpation, prolonged sitting, and physical activity. Conservative treatments, such as radial shockwave therapy and therapeutic exercises, are effective but slow, and some patients eventually require surgery. Ultrasound-guided percutaneous neuromodulation, targeting the superior gluteal nerve, has emerged as a promising alternative to improve GTPS outcomes. This technique aims to normalize motor response and reduce pain more rapidly than conventional therapies. Integrating neuromodulation could accelerate recovery, enhancing both pain relief and tendon functionality. This study aims to explore the effectiveness of this technique as an adjunct to conventional treatments, aiming for faster symptom improvement and better long-term adherence.
Eligibility Criteria
Inclusion Criteria: * Suffering from Greater Trochanteric Pain Syndrome (GTPS). * Experiencing local pain upon palpation of the greater trochanter area. * Having pain in the greater trochanter region lasting more than three months, indicating chronicity. * Being over 18 years of age. * Experiencing pain when bearing weight on the affected trochanter. * Having pain that impairs the functionality of resisted hip abduction. Exclusion Criteria: * Radiological evidence of pathology in the hip or knee joints. * Blood coagulation disorders. * Use of oral anticoagulants. * Presence of infections. * History of disc or hip surgery. * Presence of dysplasia, deformities, or sciatica. * History of vascular, neurological, or neoplastic diseases. * Specific contraindications for ultrasound-guided percutaneous neuromodulation (UG-PNM): belenophobia, pregnancy, pacemakers, epilepsy.